Product Information
GENOTROPIN 12 MG CARTRIDGE is a brand product labeled by Pfizer Inc., priced at $1810.4035 per EA under NDC 00013264681. Its NADAC has been published 94 times since Dec 18, 2024.
Manufacturer
Pfizer Inc.NDC
00013264681
Classification
Brand
Dosage Form
KIT
Effective Date
1/1/2026
Approval Type
Biologic (BLA)
FDA Application
BLA020280On Market Since
12/20/1995
Price Statistics
The NADAC for GENOTROPIN 12 MG CARTRIDGE has been published 94 times since Dec 18, 2024, and over the history we have for it it has risen 5.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1810.4035 per EA |
|---|---|
| All-time high | $1810.4035 (Sep 30, 2026) |
| All-time low | $1715.7267 (Dec 18, 2024) |
| 52-week high | $1810.4035 |
| 52-week low | $1757.6733 |
| Median price | $1757.6733 |
| Average price | $1778.2375 |
| Largest weekly change | +3.0% (Dec 31, 2025) |
| Weeks tracked | 94 |
| Tracking since | Dec 18, 2024 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 98% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Pfizer Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
somatropin market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of GENOTROPIN 12 MG CARTRIDGE?
The current National Average Drug Acquisition Cost (NADAC) for GENOTROPIN 12 MG CARTRIDGE, manufactured by Pfizer Inc., is $1810.4035 per EA (NDC 00013264681), effective Sep 30, 2026.
How has the price of GENOTROPIN 12 MG CARTRIDGE changed over time?
Over the history we have for it, the NADAC for GENOTROPIN 12 MG CARTRIDGE has risen 5.5%. It has been tracked across 94 weekly CMS publications since Dec 18, 2024.
What are the highest and lowest recorded NADAC prices for GENOTROPIN 12 MG CARTRIDGE?
Since Dec 18, 2024, the NADAC for GENOTROPIN 12 MG CARTRIDGE has ranged from a low of $1715.7267 (Dec 18, 2024) to a high of $1810.4035 (Sep 30, 2026), with a median of $1757.6733 per EA.
Are there cheaper alternatives to GENOTROPIN 12 MG CARTRIDGE?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, GENOTROPIN MINIQUICK 0.2 MG, is $30.8987 per EA — about 98% below GENOTROPIN 12 MG CARTRIDGE.
Who manufactures GENOTROPIN 12 MG CARTRIDGE?
GENOTROPIN 12 MG CARTRIDGE (NDC 00013264681) is labeled by Pfizer Inc., and CMS classifies it as a brand product.